SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001213900-17-013208
Filing Date
2017-12-14
Accepted
2017-12-13 21:44:34
Documents
12

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 TO FORM S-1 fs12017a2_akersbiosciences.htm S-1/A 6090867
2 FORM OF UNDERWRITING AGREEMENT fs12017a2ex1-1_akerbio.htm EX-1.1 366014
3 FORM OF AMENDMENT TO CERTIFICATE OF INCORPORATION, CERTIFICATE OF SERIES B PREFE fs12017a2ex3-7_akerbio.htm EX-3.7 93466
4 FORM OF UNDERWRITER'S WARRANT fs12017a2ex4-1_akerbio.htm EX-4.1 85916
5 FORM OF STOCK CERTIFICATE OF SERIES B PREFERRED STOCK fs12017a2ex4-6_akerbio.htm EX-4.6 20713
6 FORM OF COMMON STOCK PURCHASE WARRANT fs12017a2ex4-7_akerbio.htm EX-4.7 107693
7 OPINION OF LUCOSKY BROOKMAN LLP fs12017a2ex5-1_akerbio.htm EX-5.1 14044
8 CONSENT OF MORISON COGEN LLP, DATED DECEMBER 13, 2017 fs12017a2ex23-1_akerbio.htm EX-23.1 2375
9 GRAPHIC image001.jpg GRAPHIC 21467
10 GRAPHIC image002.jpg GRAPHIC 445960
11 GRAPHIC image_004.jpg GRAPHIC 14302
12 GRAPHIC image_003.jpg GRAPHIC 3475
  Complete submission text file 0001213900-17-013208.txt   7450994
Mailing Address 201 GROVE RD THOROFARE NJ 08086
Business Address 201 GROVE RD THOROFARE NJ 08086 856-848-8698
Akers Biosciences, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-221746 | Film No.: 171255068
SIC: 2835 In Vitro & In Vivo Diagnostic Substances